Helmi L Lutsep, professor, vice chair, and associate director, Oregon Stroke Center, Oregon Health and Science University, Portland, USA, discusses the results of a subanalysis of the SAMMPRIS (Stenting vs. aggressive medical therapy for intracranial arterial stenosis) trial which found lower outcome events with aggressive medical management than with stenting, even in patients who had failed antithrombotic therapy, who are perceived as being at high-risk.
Courtesy of the American Heart Association
